These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24921213)
1. Use of sunitinib in a 30-year-old woman with pancreatic neuroendocrine tumors associated with Von Hippel-Lindau syndrome. Wang W; Jiang CY; Wang HW J Clin Gastroenterol; 2015 Jan; 49(1):89-90. PubMed ID: 24921213 [No Abstract] [Full Text] [Related]
2. An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease. Miki M; Kawabe K; Igarashi H; Abe T; Ohishi Y; Hashimoto R; Karashima T; Yamasaki I; Inoue K; Ito T; Ogawa Y Intern Med; 2018 Jul; 57(14):2007-2011. PubMed ID: 29491307 [TBL] [Abstract][Full Text] [Related]
3. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease]. Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008 [TBL] [Abstract][Full Text] [Related]
4. Sunitinib treatment of metastatic renal cell carcinoma in von Hippel-Lindau disease. Tsimafeyeu I J Cancer Res Ther; 2015; 11(4):920-2. PubMed ID: 26881543 [TBL] [Abstract][Full Text] [Related]
5. Metastatic renal cell carcinoma versus pancreatic neuroendocrine tumor in von Hippel-Lindau disease: treatment with interleukin-2. Williams C; Walther M ScientificWorldJournal; 2005 Jan; 5():9-10. PubMed ID: 15674444 [TBL] [Abstract][Full Text] [Related]
7. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Jonasch E; McCutcheon IE; Waguespack SG; Wen S; Davis DW; Smith LA; Tannir NM; Gombos DS; Fuller GN; Matin SF Ann Oncol; 2011 Dec; 22(12):2661-2666. PubMed ID: 22105611 [TBL] [Abstract][Full Text] [Related]
8. Targeted therapies: Good news for advanced-stage pancreatic neuroendocrine tumors. Spiegel AM; Libutti SK Nat Rev Clin Oncol; 2011 May; 8(5):258-9. PubMed ID: 21448150 [No Abstract] [Full Text] [Related]
9. Response to Somatostatin Analog Therapy in a Patient With von Hippel-Lindau Disease and Multiple Pancreatic Neuroendocrine Tumors. OʼToole SM; Drake WM Pancreas; 2017 Aug; 46(7):e57. PubMed ID: 28697140 [No Abstract] [Full Text] [Related]
14. Severe perirenal hematoma in a patient with a single kidney treated with sunitinib for metastatic pancreatic neuroendocrine tumor. Zugazagoitia J; Sastre J; Barrera J; García B; Díaz-Rubio E J Cancer Res Ther; 2012; 8(2):303-5. PubMed ID: 22842382 [TBL] [Abstract][Full Text] [Related]
15. Advances in pancreatic neuroendocrine tumor treatment. van der Veldt AA; Kleijn SA N Engl J Med; 2011 May; 364(19):1873; author reply 1873-5. PubMed ID: 21561355 [No Abstract] [Full Text] [Related]
16. New target therapies for patients with neuroendocrine tumors of the pancreas. Baltogiannis G; Katsios C; Roukos DH Expert Rev Gastroenterol Hepatol; 2011 Oct; 5(5):563-6. PubMed ID: 21910571 [No Abstract] [Full Text] [Related]
17. Promising advances in the treatment of malignant pancreatic endocrine tumors. Jensen RT; Delle Fave G N Engl J Med; 2011 Feb; 364(6):564-5. PubMed ID: 21306243 [No Abstract] [Full Text] [Related]
18. New treatments of pancreatic neuroendocrine tumors: why using them? How to use them? Raymond E; Ruszniewski P Target Oncol; 2012 Jun; 7(2):91-2. PubMed ID: 22669625 [No Abstract] [Full Text] [Related]
19. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. Raymond E; Dahan L; Raoul JL; Bang YJ; Borbath I; Lombard-Bohas C; Valle J; Metrakos P; Smith D; Vinik A; Chen JS; Hörsch D; Hammel P; Wiedenmann B; Van Cutsem E; Patyna S; Lu DR; Blanckmeister C; Chao R; Ruszniewski P N Engl J Med; 2011 Feb; 364(6):501-13. PubMed ID: 21306237 [TBL] [Abstract][Full Text] [Related]
20. Advances in pancreatic neuroendocrine tumor treatment. Berruti A; Pia A; Terzolo M N Engl J Med; 2011 May; 364(19):1871-2; author reply 1873-4. PubMed ID: 21561357 [No Abstract] [Full Text] [Related] [Next] [New Search]